Cabrera Osmir, Martínez Miguel E, Cuello Maribel, Soto Carmen R, Valmaseda Tania, Cedré Bárbara, González Gustavo Sierra
Immunology Department, Finlay Institute, 27 Ave. No. 19805, PO. Box 16017, Havana, Cuba.
Vaccine. 2006 Apr 12;24 Suppl 2:S2-74-5. doi: 10.1016/j.vaccine.2005.01.130.
The lipopolysaccharide (LPS) of Vibrio cholerae is considered one of the most important antigens from the point of view of immunogenicity in these bacteria. We have undertaken detoxification of this LPS by basic hydrolysis and the resultant amine groups were used for their conjugation to tetanus toxoid as carrier protein using carbodiimide-mediated coupling. The resulting conjugates were inoculated in Balb/c mice for immunogenicity studies. The anti-LPS IgG and vibriocidal antibodies were measured in serum. The antigenicity of this conjugated was evaluated by ELISA, with serums of humans vaccinated with a strain genetically modified. The conjugated elicited: high titers of IgG anti-LPS, high titers of vibriocidal antibodies and there was recognition of LPS by antibodies from cholerae immunised human serum. These results show that the conjugated LPS obtained by us, could be evaluated like a potential vaccine for human use.
从免疫原性角度来看,霍乱弧菌的脂多糖(LPS)被认为是这些细菌中最重要的抗原之一。我们通过碱水解对这种LPS进行解毒,并使用碳二亚胺介导的偶联反应,将所得的胺基与破伤风类毒素作为载体蛋白进行偶联。将所得的偶联物接种到Balb/c小鼠中进行免疫原性研究。检测血清中的抗LPS IgG和杀弧菌抗体。通过ELISA评估这种偶联物的抗原性,使用接种了基因改造菌株的人类血清。该偶联物引发了:高滴度的抗LPS IgG、高滴度的杀弧菌抗体,并且霍乱免疫的人血清抗体能够识别LPS。这些结果表明,我们获得的偶联LPS可作为一种潜在的人用疫苗进行评估。